Evidence for a transport carrier of nitrogen mustard in nitrogen mustard-sensitive and -resistant L5178Y lymphoblasts.
Gerald J. Goldenberg, C L Vanstone, L. G. Israels, D Iise, I. Bihler
Abstract
Gerald J. Goldenberg, C L Vanstone, L. G. Israels, D Iise, I. Bihler
Abstract
Summary Uptake of nitrogen mustard (HN2)- 14 C by HN2-sensitive and -resistant L5178Y lymphoblasts followed simple Michaelis-Menten kinetics and demonstrated chemical specificity. Hydrolyzed HN2 and the monofunctional analog, dimethyl 2-chloroethylamine, inhibited uptake of HN2- 14 C, and the kinetics were those of competitive inhibition. Other structural analogs of HN2 such as chlorambucil, melphalan, and cyclophosphamide did not inhibit drug uptake. Transport proceeded against a concentration gradient as high as 35-fold and was almost completely inhibited at 4° and partially inhibited by ouabain and 2,4-dinitrophenol. These findings suggest that transport of HN2 is carrier-mediated and is an active process. The K m for resistant cells was higher than that of sensitive cells, suggesting a decreased affinity of the transport carrier for drug. The V max of resistant cells was lower than that of sensitive lymphoblasts, suggesting decreased transport capacity in resistant cells. The binding of HN2- 14 C to DNA, RNA, and protein of resistant lymphoblasts was significantly lower than that observed in each of the corresponding fractions of HN2-sensitive cells. The data suggest that resistance to HN2 is multifactorial, one factor being decreased uptake of HN2 by resistant cells.
OpenAlex reports 100 citations for this work. Citation counts describe recorded attention and do not establish research quality.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
Summary Uptake of nitrogen mustard (HN2)- 14 C by HN2-sensitive and -resistant L5178Y lymphoblasts followed simple Michaelis-Menten kinetics and demonstrated chemical specificity. Hydrolyzed HN2 and the monofunctional analog, dimethyl 2-chloroethylamine, inhibited uptake of HN2- 14 C, and the kinetics were those of competitive inhibition. Other structural analogs of HN2 such as chlorambucil, melphalan, and cyclophosphamide did not inhibit drug uptake. Transport proceeded against a concentration gradient as high as 35-fold and was almost completely inhibited at 4° and partially inhibited by ouabain and 2,4-dinitrophenol. These findings suggest that transport of HN2 is carrier-mediated and is an active process. The K m for resistant cells was higher than that of sensitive cells, suggesting a decreased affinity of the transport carrier for drug. The V max of resistant cells was lower than that of sensitive lymphoblasts, suggesting decreased transport capacity in resistant cells. The binding of HN2- 14 C to DNA, RNA, and protein of resistant lymphoblasts was significantly lower than that observed in each of the corresponding fractions of HN2-sensitive cells. The data suggest that resistance to HN2 is multifactorial, one factor being decreased uptake of HN2 by resistant cells.
Key concepts: Nitrogen mustard, Lymphoblast, Chemistry, Melphalan, Biochemistry, Chlorambucil, Kinetics, Enzyme